RBM15B

Across TCGA pan-cancer cohorts, RBM15B RNA differs between tumor and matched normal tissue in 9 of 18 cancer types tested, making tumor–normal expression one of RBM15B’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where RBM15B RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RBM15B is over-expressed in tumor.

LIHC, KIRP, and COAD are the cancer types where RBM15B tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RBM15B RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	Female	II,III,IV	+1.199	<.001	9	view →
KIRP	All	All	+0.443	<.001	8	view →
COAD	All	All	+0.362	<.001	7	view →
CHOL	All	II,III,IV	+2.210	<.001	5	view →
STAD	All	II,III,IV	+0.658	.001	4	view →
LUAD	Male	All	+0.282	.014	4	view →
HNSC	Male	All	+0.394	.009	3	view →
PRAD	All	All	+0.456	<.001	2	view →
LUSC	All	All	+0.215	.011	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 9 strongest of 9 lineages.

RBM15B–LIHC

Open the LIHC breakdown →